123 related articles for article (PubMed ID: 29848291)
1. Quantitative nuclear histomorphometry predicts oncotype DX risk categories for early stage ER+ breast cancer.
Whitney J; Corredor G; Janowczyk A; Ganesan S; Doyle S; Tomaszewski J; Feldman M; Gilmore H; Madabhushi A
BMC Cancer; 2018 May; 18(1):610. PubMed ID: 29848291
[TBL] [Abstract][Full Text] [Related]
2. Oncotype DX breast cancer recurrence score can be predicted with a novel nomogram using clinicopathologic data.
Orucevic A; Bell JL; McNabb AP; Heidel RE
Breast Cancer Res Treat; 2017 May; 163(1):51-61. PubMed ID: 28243897
[TBL] [Abstract][Full Text] [Related]
3. A study of association of Oncotype DX recurrence score with DCE-MRI characteristics using multivariate machine learning models.
Saha A; Harowicz MR; Wang W; Mazurowski MA
J Cancer Res Clin Oncol; 2018 May; 144(5):799-807. PubMed ID: 29427210
[TBL] [Abstract][Full Text] [Related]
4. In ER-Positive, HER2-Negative Breast Cancers, HER2 mRNA Levels Correlate Better with Clinicopathologic Features and Oncotype DX Recurrence Score than HER2 Immunohistochemistry.
Tyburski H; Karakas C; Finkelman BS; Turner BM; Zhang H; Hicks DG
Lab Invest; 2024 Mar; 104(3):100309. PubMed ID: 38135156
[TBL] [Abstract][Full Text] [Related]
5. Is Oncotype DX testing informative for breast cancers with low ER expression? A retrospective review from a biomarker testing referral center.
Loggie J; Barnes PJ; Carter MD; Rayson D; Bethune GC
Breast; 2024 Jun; 75():103715. PubMed ID: 38520994
[TBL] [Abstract][Full Text] [Related]
6. Correlation of Ki-67 proliferative index with oncotype DX recurrence score in hormone receptor-positive, human epidermal growth factor receptor 2-negative early breast cancer with low-burden axillary nodal disease - a review of 137 cases.
Saad Abdalla Al-Zawi A; Anichkina KA; Elamass M; Aladili Z
Pol J Pathol; 2024; 75(1):8-18. PubMed ID: 38741425
[TBL] [Abstract][Full Text] [Related]
7. Comparison of breast cancer prognostic tests CanAssist Breast and Oncotype DX.
Sengupta AK; Gunda A; Malpani S; Serkad CPV; Basavaraj C; Bapat A; Bakre MM
Cancer Med; 2020 Nov; 9(21):7810-7818. PubMed ID: 33027559
[TBL] [Abstract][Full Text] [Related]
8. A new methodology to predict the oncotype scores based on clinico-pathological data with similar tumor profiles.
Al Masry Z; Pic R; Dombry C; Devalland C
Breast Cancer Res Treat; 2024 Feb; 203(3):587-598. PubMed ID: 37926760
[TBL] [Abstract][Full Text] [Related]
9. Association Between Ki-67 Proliferative Index and Oncotype-Dx Recurrence Score in Hormone Receptor-Positive, HER2-Negative Early Breast Cancers. A Systematic Review of the Literature.
Mooghal M; Khan MAA; Samar MR; Shaikh H; Valimohammad AT; Idrees R; Abdul Rashid Y; Sattar AK
Breast Cancer (Auckl); 2024; 18():11782234241255211. PubMed ID: 38779417
[TBL] [Abstract][Full Text] [Related]
10. Benefits of introduction of Oncotype DX
Green N; Al-Allak A; Fowler C
Ann R Coll Surg Engl; 2019 Jan; 101(1):55-59. PubMed ID: 30322288
[TBL] [Abstract][Full Text] [Related]
11. The added value of ultrasound imaging biomarkers to clinicopathological factors for the prediction of high-risk Oncotype DX recurrence scores in patients with breast cancer.
Luo Y; Gao Y; Niu Z; Zhang J; Liu Z; Zhang Y; Shen S; Jiang Y; Xiao M; Zhu Q
Quant Imaging Med Surg; 2024 May; 14(5):3519-3533. PubMed ID: 38720854
[TBL] [Abstract][Full Text] [Related]
12. Propensity score analysis of the prognostic value of genomic assays for breast cancer in diverse populations using the National Cancer Data Base.
Ibraheem A; Olopade OI; Huo D
Cancer; 2020 Sep; 126(17):4013-4022. PubMed ID: 32521056
[TBL] [Abstract][Full Text] [Related]
13. Multi-Pass Adaptive Voting for Nuclei Detection in Histopathological Images.
Lu C; Xu H; Xu J; Gilmore H; Mandal M; Madabhushi A
Sci Rep; 2016 Oct; 6():33985. PubMed ID: 27694950
[TBL] [Abstract][Full Text] [Related]
14. Addressing Social Determinants in the Era of Precision Medicine in Breast Cancer: Is It Sufficient to Reduce Disparities?
Freeman JQ; Huo D
Cancer Epidemiol Biomarkers Prev; 2024 May; 33(5):635-637. PubMed ID: 38689576
[TBL] [Abstract][Full Text] [Related]
15. Analytical Validation of the PreciseDx Digital Prognostic Breast Cancer Test in Early-Stage Breast Cancer.
Fernandez G; Zeineh J; Prastawa M; Scott R; Madduri AS; Shtabsky A; Jaffer S; Feliz A; Veremis B; Mejias JC; Charytonowicz E; Gladoun N; Koll G; Cruz K; Malinowski D; Donovan MJ
Clin Breast Cancer; 2024 Feb; 24(2):93-102.e6. PubMed ID: 38114366
[TBL] [Abstract][Full Text] [Related]
16. Predicting early breast cancer recurrence from histopathological images in the Carolina Breast Cancer Study.
Shi Y; Olsson LT; Hoadley KA; Calhoun BC; Marron JS; Geradts J; Niethammer M; Troester MA
NPJ Breast Cancer; 2023 Nov; 9(1):92. PubMed ID: 37952058
[TBL] [Abstract][Full Text] [Related]
17. Training a cell-level classifier for detecting basal-cell carcinoma by combining human visual attention maps with low-level handcrafted features.
Corredor G; Whitney J; Arias V; Madabhushi A; Romero E
J Med Imaging (Bellingham); 2017 Apr; 4(2):021105. PubMed ID: 28382314
[TBL] [Abstract][Full Text] [Related]
18. Comparative survival analysis of multiparametric tests-when molecular tests disagree-A TEAM Pathology study.
Bartlett JMS; Bayani J; Kornaga E; Xu K; Pond GR; Piper T; Mallon E; Yao CQ; Boutros PC; Hasenburg A; Dunn JA; Markopoulos C; Dirix L; Seynaeve C; van de Velde CJH; Stein RC; Rea D
NPJ Breast Cancer; 2021 Jul; 7(1):90. PubMed ID: 34238931
[TBL] [Abstract][Full Text] [Related]
19. Machine Learning Analysis for Quantitative Discrimination of Dried Blood Droplets.
Hamadeh L; Imran S; Bencsik M; Sharpe GR; Johnson MA; Fairhurst DJ
Sci Rep; 2020 Feb; 10(1):3313. PubMed ID: 32094359
[TBL] [Abstract][Full Text] [Related]
20. Identification of Gene Expression in Different Stages of Breast Cancer with Machine Learning.
Abidalkareem A; Ibrahim AK; Abd M; Rehman O; Zhuang H
Cancers (Basel); 2024 May; 16(10):. PubMed ID: 38791943
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
